Gene chip analysis of control and bevacizumab resistant glioma tumors also showed up-regulation of STAT1-IRF1 pathway (2.6 fold and 2.91 fold up-regulation for STAT1 and IRF1, respectively, Figure 1C). Here, IRF1 is linked to glioma.